The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
-
University of Alabama Birmingham, Birmingham, Alabama, United States, 35294
Cedars-Sinai Medical Center, Los Angeles, California, United States, 90048
Sharp-Rees Stealy Medical Group, San Diego, California, United States, 92101
UCSD, San Diego, California, United States, 92121
Women's Health Care Research, San Diego, California, United States, 92123
Specialty Obstetrics of San Diego, San Diego, California, United States, 92130
Reproductive Genetics Institute, Chicago, Illinois, United States, 60602
University of Iowa Health Care, Iowa City, Iowa, United States, 52242
Henry Ford Hospital, Detroit, Michigan, United States, 48202
Spectrum Health, Grand Rapids, Michigan, United States, 49503
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
FEMALE
No
Sequenom, Inc.,
Daniel Grosu, MD, STUDY_DIRECTOR, Sequenom, Inc.
2026-03